Promising New Therapy for Hematologic Malignancies in Young Patients
February 28th 2024Alice Bertaina, MD, discusses combining of T-allo10, a donor-derived cell product, with haploidentical stem cell transplants for the treatment of pediatric and young adult patients with hematologic malignancies.
Watch
Driving Precision Medicine Through Molecular Testing in NSCLC
February 26th 2024Patrick Forde, MBBCh, and Tina Cascone, MD, PhD, discuss the role of molecular profiling to guide precision treatment decisions in non-small cell lung cancer, including the impact of PD-L1 status on neoadjuvant and perioperative approaches.
Watch
Similar HRQOL With Gilteritinib vs Placebo in FLT3-ITD+ AML Post-HCT
February 23rd 2024Betty K. Hamilton, MD, discusses findings from a study comparing gilteritinib vs placebo post-allogeneic hematopoietic cell transplantation for the treatment of patients with FLT3-ITD-positive acute myeloid leukemia.
Watch